Alpine Global Management, LLC Vericel Corp Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 15, 2018
SELL
$9.6 - $14.6 $120,240 - $182,865
-12,525 Closed
0 $0
Q1 2018

May 16, 2018
SELL
$5.7 - $12.3 $76,089 - $164,192
-13,349 Reduced 51.59%
12,525 $125,000
Q4 2017

Feb 14, 2018
BUY
$3.65 - $5.98 $94,440 - $154,726
25,874
25,874 $141,000

Others Institutions Holding VCEL

# of Institutions
275
Shares Held
48.4M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email